Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 32 of the 45 sources its claims cite were checked for support.

mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes

Open access
Kolivas, Despina, Fraser, Liz, Schweitzer, Ronald, Brukner, Peter, Moschonis, George · 2025 · npj Metabolic Health and Disease

Abstract

Low carbohydrate diets (LCD) have shown efficacy in managing clinical outcomes in type 2 diabetes (T2D). Incorporating digital tools into health care provides an adjunct treatment modality, to educate patients and provide clinical support. This study examines the effect of a mobile health (mHealth) LCD application (app) on glycaemic profile, blood pressure and weight status, in people with T2D. The study is an online single-arm, pre-post study that recruited people with T2D from around Australia, referred via registered supporting general practitioners (GPs). The intervention (Defeat Diabetes app) provides education and resources on the use of a LCD for ongoing management of T2D. After 3 months, our cohort of 99 participants (mean age 59 ± 11 years, 55 females) showed reduced dietary carbohydrate intake as a proportion of overall energy (−14%kJ/day, 95% CI: −17 to −11). Improvement in the primary outcome HbA1c (−1.0%, 95% CI: −1.3 to −0.7), was associated with reduction in dietary carbohydrate intake. Systolic blood pressure (SBP) improved (−6 mmHg, 95% CI: −10 to −1), while 21 participants reduced their diabetes medication dose with two participants discontinuing all diabetes medication. These findings demonstrate that people with T2D receiving LCD education and resources through the Defeat Diabetes app for 3 months improved their glycaemic profile and SBP despite decreased overall medication usage in almost one third of the study sample prescribed medication at baseline.

Overview

CoChat Summary

TL;DR

In an online single-arm pre-post study of 99 Australian adults with type 2 diabetes, a mobile health low-carbohydrate app intervention was associated with improved glycaemic control, systolic blood pressure, and dietary carbohydrate reduction after 3 months. The authors conclude the Defeat Diabetes app may be a useful additional tool for lifestyle management of T2D.

Key findings

  • After 3 months, HbA1c decreased by −1.0% (95% CI: −1.3 to −0.7) and fasting plasma glucose by −1.3 mmol/L (95% CI: −2.1 to −0.6); 52% of participants reduced HbA1c to below 6.5%.
  • Dietary carbohydrate intake fell by −14% kJ/day (95% CI: −17 to −11), total energy intake fell by −1570 kJ/day (95% CI: −2128 to −1013), protein increased by 6% kJ/day (95% CI: 4–7), and total fat increased by 9% kJ/day (95% CI: 6–11).
  • Systolic blood pressure decreased by −6 mmHg (95% CI: −10 to −1); no significant changes were found in diastolic blood pressure, waist circumference, body weight, or BMI.
  • Medication changes: 21 participants reduced their diabetes medication dose and 2 discontinued all diabetes medication; 5 reduced hypertension medication dose and 3 discontinued all hypertension medications.

Methods

  • Online single-arm, pre-post study following participants over 12 months, reporting 3-month outcomes; participants with T2D were recruited from around Australia via registered supporting GPs, with data collected October 2022 to May 2024.
  • The intervention was the Defeat Diabetes app, a subscription-based mHealth program providing low-carbohydrate education, recipes, meal plans, food lists, exercise plans, and optional peer support; n = 99 participants (55 females; mean age 58.4 ± 11.3 years in Table 1).
  • Primary outcome was change in HbA1c from GP-provided REDCap data; secondary outcomes included FPG, blood pressure, anthropometrics, and medication use. Dietary intake was assessed by 3-day food records or 24-h recalls, physical activity by IPAQ, and analyses used univariate linear regression adjusted for sex, age, time since diagnosis, co-existing conditions, and dietary carbohydrate reduction, plus Chi-square tests for categorical variables.

Limitations

  • Stated: no control group; food records may not reflect eating behaviour over the whole intervention and some participants had already reduced carbohydrate intake before consent; digital competence was not assessed; not all participants used Facebook for peer support; GP referral meant the number of non-participants was unknown; missing data occurred for bloodwork, blood pressure, weight, and waist circumference; and no standardised procedures were used for anthropometry or blood pressure measurement.
  • Stated: small sample size limited gender comparisons, and the cohort had a smaller proportion of males and longer median diabetes duration in females, which may explain lesser HbA1c reductions in females.
  • Evident from the design: the single-arm pre-post design cannot establish causality, and the 3-month follow-up cannot show longer-term sustainability or remission.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s44324-025-00053-6

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Study process and recruitment.
Fig. 1 Study process and recruitment.CC BY · PubMed Central
Fig. 2 Percentage of participants categorised by reduction in HbA1c level from baseline to the 3-month follow-up. I indicates improvement (reduction) in HbA1c.
Fig. 2 Percentage of participants categorised by reduction in HbA1c level from baseline to the 3-month follow-up. I indicates improvement (reduction) in HbA1c.CC BY · PubMed Central
Fig. 3 Participants as grouped by HbA1c at baseline and after 3 months of intervention. All participants at baseline had recorded a HbA1c of 6.5% or greater as part of the eligibility criteria.
Fig. 3 Participants as grouped by HbA1c at baseline and after 3 months of intervention. All participants at baseline had recorded a HbA1c of 6.5% or greater as part of the eligibility criteria.CC BY · PubMed Central

Verification

Claims the paper makes

17 Valid · 3 Not valid · 2 Not checked · 76 Own results and interpretations

45 more claims · 7 with their cited sources checked

Create a free account to see all 98 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 27
  • It may state two separate claims as one. 32
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 33 references

Cited by

See all 7

Metadata

Authors
Kolivas, D., Fraser, L., Schweitzer, R., Brukner, P., & Moschonis, G.
Affiliations
  • La Trobe University (AU)
  • Monash University (AU)
Corresponding author
  • Kolivas, Despina
  • Moschonis, George
Venue
npj Metabolic Health and Disease
Published
2025-04-08
Volume
3
Issue
1
Pages
12-12
ISSN
2948-2828 (ISSN-L)
OpenAlex
W4409266593
Cited by
7
References
33
Citations by year
2026: 6 · 2025: 1
FWCI
4.50
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Metabolic Health and Disease (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • La Trobe University Industry Funded Research Scholarship in conjunction with Defeat Diabetes
  • La Trobe University
Topics
  • Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, low-carbohydrate diet, mobile health, glycemic control, HbA1c, systolic blood pressure, weight status, carbohydrate intake, diabetes medication reduction, patient education

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes. https://app.cochat.ai/papers/10.1038/s44324-025-00053-6
The paper
Kolivas, D., Fraser, L., Schweitzer, R., Brukner, P., & Moschonis, G. (2025). mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes. npj Metabolic Health and Disease. https://doi.org/10.1038/s44324-025-00053-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.